On Jan 29, 2026 Oncor (PUCT docket 58306) filed an unopposed settlement: annual revenue requirement…
Filed with the SEC on · Summarized by InvestorsBot
On Jan 29, 2026 Oncor (PUCT docket 58306) filed an unopposed settlement: annual revenue requirement ~$6.975B (+8.8% / ≈$560M increase). ROE 9.75%, cost of debt 4.94%, capital structure 56.5% debt / 43.5% equity; self-insurance accrual $200M. $SRE 🏛️ #utilities #PUCT
Sempra owns 80.25% of Oncor. PUCT final order expected H1 2026; new rates would follow and, if approved, Oncor will surcharge differences back to Jan 1, 2026. Sempra expects potential positive impacts to earnings, cash flow and credit metrics. $SRE ⚡ #Oncor #Regulation
Settlement includes 5-year amortization of applicable regulatory assets/liabilities (excludes rate-case expenses, 2024 deferred system resiliency costs & excess ADIT). PUCT may adopt/modify/reject—outcome remains subject to regulatory risk. $SRE 📄 #risk #utilities